8-K - Indivior Pharmaceuticals, Inc. (0001625297) (Filer)
Published . Updated .
8-K - Indivior Pharmaceuticals filed an 8-K with the SEC on Oct 29 (a notice of a material company event).
Directly affected
- INDV Indivior Pharmaceuticals-1.4% 19d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- LLY Eli Lilly and+21.6% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- JNJ Johnson & Johnson+1.5% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- PFE Pfizer+8.9% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- MRK Merck+3.2% 18d
Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| INDV | +1.67% | -0.49% | base | +1.44% | +1.81% | after close | after close |
| XLVNo price data for this ticker | — | — | — | — | — | — | — |
| XBINo price data for this ticker | — | — | — | — | — | — | — |
| LLYNo price data for this ticker | — | — | — | — | — | — | — |
| JNJNo price data for this ticker | — | — | — | — | — | — | — |
| PFENo price data for this ticker | — | — | — | — | — | — | — |
| MRKNo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Filed: 2026-10-29 AccNo: 0001193125-26-436953 Size: 351 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
The price since 29 Oct 2026: Indivior Pharmaceuticals (INDV) versus the S&P 500
| Company | When | Move | Status |
|---|---|---|---|
| Indivior Pharmaceuticals (INDV) | that day | +1.44% | final price |
| Indivior Pharmaceuticals (INDV) | the next day | +1.81% | final price |
| Indivior Pharmaceuticals (INDV) | three days earlier | -0.49% | final price |
| Indivior Pharmaceuticals (INDV) | five days earlier | +1.67% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 55 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 34 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 51 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 55 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 55 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 69 days before publication. Filed 8 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 31 Jul 2026. That is 90 days before publication. Filed 22 Sep 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 35 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 71 days before publication. Filed 9 Sep 2026. View the filing.
- Donald J Trump, an executive branch official, sold Merck (MRK), worth $250,001 - $500,000 on 31 Jul 2026. That is 90 days before publication. Filed 22 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Indivior Pharmaceuticals (INDV)
Companies mentioned with this story
- INDV Indivior Pharmaceuticals
For “8-K - Indivior Pharmaceuticals, Inc. (0001625297) (Filer),” Indivior Pharmaceuticals (INDV) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> INDV
How “8-K - Indivior Pharmaceuticals, Inc. (0001625297) (Filer)” reaches Indivior Pharmaceuticals (INDV)
The 29 Oct 2026 story “8-K - Indivior Pharmaceuticals, Inc. (0001625297) (Filer)” names Indivior Pharmaceuticals (INDV) because of this story.
The link for Indivior Pharmaceuticals (INDV) is this: SEC 8-K filing -> direct issuer disclosure -> INDV
Dates in the story, and the Indivior Pharmaceuticals (INDV) price range
INDV traded between 32.31 and 36.98 across 19 sessions. The latest close on file is 35.40.
How strong the case is around Indivior Pharmaceuticals (INDV)
14 out of 100
“8-K - Indivior Pharmaceuticals, Inc. (0001625297) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.